With the power of robotics and the personalized medicine expertise of one of Japan's top drugmakers, Astellas Pharma and Yaskawa Electric Corporation are setting off on a joint venture to help ...
Breakthrough system substantially increases cell production, with the potential to reach much higher productivity driven by platform’s significant scalability Flexible, industrial scale cell ...
LONDON--(BUSINESS WIRE)--Mytos, an innovative leader in automated cell manufacturing, announced today it has closed $19M in Series A financing led by Buckley Ventures, with participation from IQ ...
After several years spent honing its robotic cell therapy manufacturing system, Multiply Labs has snared its first collaboration with a major cell therapy developer. Multiply Labs and Legend ...
According to Germany’s Federal Ministry for Economic Affairs and Climate Action, battery cells are gaining in importance as a versatile and efficient means of storing energy. They are a driving force ...
Automated cell manufacturing company Mytos has signed an agreement with Aspen Neuroscience, a clinical-stage private company focused on autologous regenerative medicine, to automate the manufacture of ...
Engineers from The University of Warwick's Integrative Synthetic Biology Center and Imperial College London's Department of Bioengineering have unveiled how to engineer microbial "cell-factories" to ...
This review article highlights the transformative potential of in vivo CAR T cell therapy in addressing the limitations of traditional CAR T cell production. This innovative approach could ...
Creative 3D Technologies (C3DT) announced today that its EVO platform has been recognized with two CES® 2026 Innovation Awards. Creative 3D was first publicly shown at CES years ago. It’s both ...
CARLSBAD, Calif.--(BUSINESS WIRE)-- Lineage Cell Therapeutics, Inc. (LCTX) (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel allogeneic, or “off the shelf”, cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results